Business

The recent approval of Merck’s monoclonal antibody treatment, Enflonsia, by the Food and Drug Administration heralds a monumental shift in how we combat respiratory syncytial virus (RSV) in infants. This isn’t merely another drug entering the ever-crowded pharmaceutical marketplace; it’s a vital intervention that promises to save lives. Every year, RSV claims hundreds of innocent
0 Comments
In the ever-evolving landscape of air travel, the competition among U.S. airlines for international business-class supremacy has taken on a luxurious tone reminiscent of elite club memberships rather than simple travel experiences. Delicacies like caviar and plush amenities such as Bang & Olufsen headphones have become staple offerings in the battle for affluent travelers. With
0 Comments